These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 20497908)
1. Neurons associated with aggrecan-based perineuronal nets are protected against tau pathology in subcortical regions in Alzheimer's disease. Morawski M; Brückner G; Jäger C; Seeger G; Arendt T Neuroscience; 2010 Sep; 169(3):1347-63. PubMed ID: 20497908 [TBL] [Abstract][Full Text] [Related]
2. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex. van de Nes JA; Nafe R; Schlote W Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153 [TBL] [Abstract][Full Text] [Related]
3. Aggrecan-based extracellular matrix shows unique cortical features and conserved subcortical principles of mammalian brain organization in the Madagascan lesser hedgehog tenrec (Echinops telfairi Martin, 1838). Morawski M; Brückner G; Jäger C; Seeger G; Künzle H; Arendt T Neuroscience; 2010 Feb; 165(3):831-49. PubMed ID: 19682554 [TBL] [Abstract][Full Text] [Related]
4. Perineuronal nets are largely unaffected in Alzheimer model Tg2576 mice. Morawski M; Pavlica S; Seeger G; Grosche J; Kouznetsova E; Schliebs R; Brückner G; Arendt T Neurobiol Aging; 2010 Jul; 31(7):1254-6. PubMed ID: 18829133 [TBL] [Abstract][Full Text] [Related]
5. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Baig S; Wilcock GK; Love S Acta Neuropathol; 2005 Oct; 110(4):393-401. PubMed ID: 16133543 [TBL] [Abstract][Full Text] [Related]
6. The neuronal extracellular matrix restricts distribution and internalization of aggregated Tau-protein. Suttkus A; Holzer M; Morawski M; Arendt T Neuroscience; 2016 Jan; 313():225-35. PubMed ID: 26621125 [TBL] [Abstract][Full Text] [Related]
7. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H; Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444 [TBL] [Abstract][Full Text] [Related]
8. Aggrecan-based extracellular matrix is an integral part of the human basal ganglia circuit. Brückner G; Morawski M; Arendt T Neuroscience; 2008 Jan; 151(2):489-504. PubMed ID: 18055126 [TBL] [Abstract][Full Text] [Related]
9. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins). Bramblett GT; Trojanowski JQ; Lee VM Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956 [TBL] [Abstract][Full Text] [Related]
10. Perineuronal nets potentially protect against oxidative stress. Morawski M; Brückner MK; Riederer P; Brückner G; Arendt T Exp Neurol; 2004 Aug; 188(2):309-15. PubMed ID: 15246831 [TBL] [Abstract][Full Text] [Related]
11. Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas. Arendt T; Brückner MK; Bigl V; Marcova L J Comp Neurol; 1995 Jan; 351(2):223-46. PubMed ID: 7699112 [TBL] [Abstract][Full Text] [Related]
12. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. Papasozomenos SC Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060 [TBL] [Abstract][Full Text] [Related]
13. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons. Chalmers KA; Love S J Neuropathol Exp Neurol; 2007 Feb; 66(2):158-67. PubMed ID: 17279001 [TBL] [Abstract][Full Text] [Related]
14. Expression of tau mRNA and soluble tau isoforms in affected and non-affected brain areas in Alzheimer's disease. Boutajangout A; Boom A; Leroy K; Brion JP FEBS Lett; 2004 Oct; 576(1-2):183-9. PubMed ID: 15474035 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of tau accumulation in early stages of Alzheimer-type neurofibrillary lesions. Togo T; Akiyama H; Iseki E; Uchikado H; Kondo H; Ikeda K; Tsuchiya K; de Silva R; Lees A; Kosaka K Acta Neuropathol; 2004 Jun; 107(6):504-8. PubMed ID: 15024583 [TBL] [Abstract][Full Text] [Related]
16. [Significance of tau in the development of Alzheimer's disease]. Takashima A Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874 [TBL] [Abstract][Full Text] [Related]
17. Distribution and classification of aggrecan-based extracellular matrix in the thalamus of the rat. Gáti G; Morawski M; Lendvai D; Jäger C; Négyessy L; Arendt T; Alpár A J Neurosci Res; 2010 Nov; 88(15):3257-66. PubMed ID: 20857510 [TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Barrachina M; Puig B Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379 [TBL] [Abstract][Full Text] [Related]
19. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease. Boche D; Donald J; Love S; Harris S; Neal JW; Holmes C; Nicoll JA Acta Neuropathol; 2010 Jul; 120(1):13-20. PubMed ID: 20532897 [TBL] [Abstract][Full Text] [Related]
20. The expression of calcium/calmodulin-dependent protein kinase II-alpha in the hippocampus of patients with Alzheimer's disease and its links with AD-related pathology. Wang YJ; Chen GH; Hu XY; Lu YP; Zhou JN; Liu RY Brain Res; 2005 Jan; 1031(1):101-8. PubMed ID: 15621017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]